One-year creatinine predicts long-term graft survival in pediatric kidney transplant recipients

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: In pediatric kidney transplant recipients long-term graft survival remains variable necessitating methods to predict the timing of graft failure. Studies in adults have identified post-transplant serum creatinine (sCr) as a biomarker for graft survival. Our goal was to investigate the predictive value of one-year sCr levels on long-term graft survival in pediatric kidney recipients. Methods: We performed a retrospective cohort study of Organ Procurement and Transplantation Network data. We identified 8,733 pediatric kidney transplant recipients between 2008 and 2021 with reported one-year sCr levels. Patients were grouped by sCr level: ≤1.0, 1.0-1.5, 1.5-2.0, and ³2.0 mg/dL. We analyzed long-term graft survival with a Kaplan-Meier curve and a multivariable Cox-proportional hazard model. We developed a predictive score derived from a sCr based model and an estimated glomerular filtration rate (eGFR) based model and compared them using DeLong’s test. Results: Mean one-year sCr was 0.88 mg/dL, and higher one-year sCr predicted long-term graft failure (sCr 1.0 to 1.5 adjusted hazard ratio (aHR) 1.73, sCr 1.5 to 2.0 aHR 2.64, sCr ³2.0 aHR 6.92, p<0.001 for all). The mean one-year eGFR was 71.66 mL/min/1.73m². Compared to patients with eGFR ≥90, risk of graft failure increased stepwise with lower eGFR (eGFR 60-90 aHR 1.27, eGFR 45-60 aHR 1.70, eGFR 30-45 aHR 2.62, eGFR <30 aHR 9.05, p<0.004 for all). Predictive ability was similar between eGFR and sCr-based models (p=0.116). Conclusions: Utilizing one-year sCr may allow for early identification of patients at risk of graft failure for careful surveillance and prognostication for patient expectations.

Article activity feed